Friday, 25 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14486
Articles
Company
Drug
Frontera Therapeutics Initiates FT-002 Clinical Study for X-Linked Retinitis Pigmentosa
January 19, 2025
Company
Drug
Kanghong’s KH617 Receives Orphan Drug Designation for Glioblastoma
January 19, 2025
Company
Drug
Luye Pharma’s BA2101 Begins Phase I Clinical Trial for Allergic Diseases
January 19, 2025
Company
Drug
CDE Accepts Clinical Trial Filing for Ranok’s First-in-Class BRD4 Degradation Drug RNK05047
January 19, 2025
Company
Drug
Junshi Biosciences and Coherus Report Positive JUPITER-02 Trial Results for NPC Treatment
January 19, 2025
Company
Deals
Eyenovia Partners with Formosa Pharmaceuticals for Ophthalmic Therapeutics
January 19, 2025
Company
Deals
Brii Biosciences Publishes Positive Phase II Results for HBV Treatment
January 19, 2025
Company
Drug
Hengrui Pharmaceuticals Gains NMPA Approval for SHR-A1921 Clinical Study
January 19, 2025
Company
Medical Device
Grand Pharma Completes First Atrial Fibrillation Treatment with HeartLight X3
January 19, 2025
Company
Drug
Zelgen’s ZG2001 and ZG0895 Clinical Trials Approved by NMPA
January 19, 2025
Company
Drug
Innovent Biologics Initiates Phase II Study for IBI311 in Thyroid-Associated Ophthalmopathy
January 19, 2025
Company
Deals
Hygea Medtech Secures Series D Funding for Oncology Device Expansion
January 19, 2025
1
2
…
1,035
1,036
1,037
1,038
1,039
…
1,207
1,208
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?